62 related articles for article (PubMed ID: 12602271)
1. Clinical characteristics of hereditary ovarian cancer (HOC) in Poland.
Menkiszak J; Górski B; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Foszczyńska-Kłoda M; Fliciński J; Brzosko M; Rzepka-Górska I; Lubiński J
Ginekol Pol; 2002 Sep; 73(9):733-9. PubMed ID: 12602271
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics of selected features of hereditary ovarian cancer in carriers of constitutional BRCA1 gene mutation].
Menkiszak J; Górski B; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Foszczyńska-Kłoda M; Fliciński J; Brzosko M; Rzepka-Górska I; Jan L
Ginekol Pol; 2002 Nov; 73(11):1084-9. PubMed ID: 12722403
[TBL] [Abstract][Full Text] [Related]
3. [Clinicopathological characteristics of hereditary ovarian cancer syndrome].
Zhong Y; Sheng XG; Ma ZF; Ma YB; Liu NF; Chen YT; Gao R; Wang YY; Sun L
Zhonghua Fu Chan Ke Za Zhi; 2009 Sep; 44(9):676-80. PubMed ID: 20079180
[TBL] [Abstract][Full Text] [Related]
4. Is low-grade serous ovarian cancer part of the tumor spectrum of hereditary breast and ovarian cancer?
Vineyard MA; Daniels MS; Urbauer DL; Deavers MT; Sun CC; Boerwinkle E; Bodurka DC; Gershenson DM; Crawford J; Lu KH
Gynecol Oncol; 2011 Feb; 120(2):229-32. PubMed ID: 21126756
[TBL] [Abstract][Full Text] [Related]
5. [Clinicalpathological characteristics of Lynch syndrome related epithelial ovarian cancer].
Ma XG; Wang YM; Xue FX; Zhang HY; Sheng HN; Qi Z; Liu GY
Zhonghua Fu Chan Ke Za Zhi; 2012 Mar; 47(3):201-4. PubMed ID: 22781072
[TBL] [Abstract][Full Text] [Related]
6. [The prevalence of BRCA1 mutations among families at high-risk of breast and ovarian cancer in province of Malopolska between 2004-2009].
Blecharz P; Szatkowski W; Klimek M; Urbański K
Przegl Lek; 2009; 66(12):1046-8. PubMed ID: 20514903
[TBL] [Abstract][Full Text] [Related]
7. Hereditary ovarian cancer in Poland.
Menkiszak J; Gronwald J; Górski B; Jakubowska A; Huzarski T; Byrski T; Foszczyńska-Kłoda M; Haus O; Janiszewska H; Perkowska M; Brozek I; Grzybowska E; Zientek H; Góźdź S; Kozak-Klonowska B; Urbański K; Miturski R; Kowalczyk J; Pluzańska A; Niepsuj S; Koc J; Szwiec M; Drosik K; Mackiewicz A; Lamperska K; Strózyk E; Godlewski D; Stawicka M; Waśko B; Bebenek M; Rozmiarek A; Rzepka-Górska I; Narod SA; Lubiński J
Int J Cancer; 2003 Oct; 106(6):942-5. PubMed ID: 12918074
[TBL] [Abstract][Full Text] [Related]
8. Familial invasive and borderline ovarian tumors by proband status, age and histology.
Hemminki K; Granström C
Int J Cancer; 2003 Jul; 105(5):701-5. PubMed ID: 12740921
[TBL] [Abstract][Full Text] [Related]
9. Analyses of p53 expression pattern and BRCA mutations in patients with double primary breast and ovarian cancer.
Bruchim I; Fishman A; Friedman E; Goldberg I; Chetrit A; Barshack I; Dekel E; Hirsh-Yechezkel G; Modan B; Kopolovic J
Int J Gynecol Cancer; 2004; 14(2):251-8. PubMed ID: 15086724
[TBL] [Abstract][Full Text] [Related]
10. The contribution of founder mutations in BRCA1 to breast cancer in Belarus.
Uglanitsa N; Oszurek O; Uglanitsa K; Savonievich E; Lubiński J; Cybulski C; Debniak T; Narod SA; Gronwald J
Clin Genet; 2010 Oct; 78(4):377-80. PubMed ID: 20507347
[TBL] [Abstract][Full Text] [Related]
11. [Mutation of breast cancer susceptibility gene in ovarian cancer and its clinical significance].
Shi H; You Z; Guo Y
Zhonghua Fu Chan Ke Za Zhi; 1998 Nov; 33(11):676-8. PubMed ID: 10806719
[TBL] [Abstract][Full Text] [Related]
12. Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.
Schrader KA; Hurlburt J; Kalloger SE; Hansford S; Young S; Huntsman DG; Gilks CB; McAlpine JN
Obstet Gynecol; 2012 Aug; 120(2 Pt 1):235-40. PubMed ID: 22776961
[TBL] [Abstract][Full Text] [Related]
13. Tumour biological features of BRCA1-induced breast and ovarian cancer.
Jóhannsson OT; Idvall I; Anderson C; Borg A; Barkardóttir RB; Egilsson V; Olsson H
Eur J Cancer; 1997 Mar; 33(3):362-71. PubMed ID: 9155518
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 and BRCA2 mutations in central and southern Italian patients.
Ottini L; D'Amico C; Noviello C; Lauro S; Lalle M; Fornarini G; Colantuoni OA; Pizzi C; Cortesi E; Carlini S; Guadagni F; Bianco AR; Frati L; Contegiacomo A; Mariani-Costantini R
Breast Cancer Res; 2000; 2(4):307-10. PubMed ID: 11056688
[TBL] [Abstract][Full Text] [Related]
15. Hereditary ovarian cancer: a clinicopathological study.
Bewtra C; Watson P; Conway T; Read-Hippee C; Lynch HT
Int J Gynecol Pathol; 1992 Jul; 11(3):180-7. PubMed ID: 1399227
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 and BRCA2 point mutations and large rearrangements in breast and ovarian cancer families in Northern Poland.
Ratajska M; Brozek I; Senkus-Konefka E; Jassem J; Stepnowska M; Palomba G; Pisano M; Casula M; Palmieri G; Borg A; Limon J
Oncol Rep; 2008 Jan; 19(1):263-8. PubMed ID: 18097605
[TBL] [Abstract][Full Text] [Related]
17. A high proportion of founder BRCA1 mutations in Polish breast cancer families.
Górski B; Jakubowska A; Huzarski T; Byrski T; Gronwald J; Grzybowska E; Mackiewicz A; Stawicka M; Bebenek M; Sorokin D; Fiszer-Maliszewska Ł; Haus O; Janiszewska H; Niepsuj S; Góźdź S; Zaremba L; Posmyk M; Płuzańska M; Kilar E; Czudowska D; Waśko B; Miturski R; Kowalczyk JR; Urbański K; Szwiec M; Koc J; Debniak B; Rozmiarek A; Debniak T; Cybulski C; Kowalska E; Tołoczko-Grabarek A; Zajaczek S; Menkiszak J; Medrek K; Masojć B; Mierzejewski M; Narod SA; Lubiński J
Int J Cancer; 2004 Jul; 110(5):683-6. PubMed ID: 15146557
[TBL] [Abstract][Full Text] [Related]
18. Intra-abdominal carcinomatosis after prophylactic oophorectomy in women of hereditary breast ovarian cancer syndrome kindreds associated with BRCA1 and BRCA2 mutations.
Casey MJ; Synder C; Bewtra C; Narod SA; Watson P; Lynch HT
Gynecol Oncol; 2005 May; 97(2):457-67. PubMed ID: 15863145
[TBL] [Abstract][Full Text] [Related]
19. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations.
Lee JS; John EM; McGuire V; Felberg A; Ostrow KL; DiCioccio RA; Li FP; Miron A; West DW; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):359-63. PubMed ID: 16492929
[TBL] [Abstract][Full Text] [Related]
20. BRCA1 gene mutations may explain more than 80% of excess number of ovarian cancer cases after breast cancer - a population based study from the Western Sweden Health Care region.
Einbeigi Z; Enerbäck C; Wallgren A; Nordling M; Karlsson P
Acta Oncol; 2010 Apr; 49(3):361-7. PubMed ID: 20151938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
